Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study.
about
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined inhaled corticosteroi ...... ation: An observational study.
@en
Combined inhaled corticosteroi ...... ation: An observational study.
@nl
type
label
Combined inhaled corticosteroi ...... ation: An observational study.
@en
Combined inhaled corticosteroi ...... ation: An observational study.
@nl
prefLabel
Combined inhaled corticosteroi ...... ation: An observational study.
@en
Combined inhaled corticosteroi ...... ation: An observational study.
@nl
P2093
P2860
P1433
P1476
Combined inhaled corticosteroi ...... ation: An observational study.
@en
P2093
P2860
P356
10.1097/MD.0000000000005116
P407
P577
2016-10-01T00:00:00Z